--- title: "Global Stocks Trading Up To 49% Below Intrinsic Value Estimates" type: "News" locale: "en" url: "https://longbridge.com/en/news/286237070.md" description: "Global markets are showing resilience, with U.S. equities rising due to strong corporate earnings and a solid labor market, while European indices gain amid easing geopolitical tensions. However, some stocks remain undervalued, presenting investment opportunities. Notable mentions include APT Medical, trading 31.5% below fair value, and LianChuang Electronic Technology, trading 49% below fair value despite recent losses. Jiangsu Haili Wind Power Equipment is also undervalued at 30.3% below fair value. Investors are encouraged to explore these opportunities and consider long-term growth potential." datetime: "2026-05-13T10:01:09.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286237070.md) - [en](https://longbridge.com/en/news/286237070.md) - [zh-HK](https://longbridge.com/zh-HK/news/286237070.md) --- # Global Stocks Trading Up To 49% Below Intrinsic Value Estimates Global markets have recently shown resilience, with U.S. equity markets rallying on the back of strong corporate earnings and a robust labor market, while European indices experienced modest gains amid easing geopolitical tensions. Despite these positive trends, certain stocks remain undervalued relative to their intrinsic value estimates, presenting potential opportunities for investors who focus on fundamentals and long-term growth prospects. ### Top 10 Undervalued Stocks Based On Cash Flows Click here to see the full list of 414 stocks from our Undervalued Global Stocks Based On Cash Flows screener. Let's take a closer look at a couple of our picks from the screened companies. ## APT Medical (SHSE:688617) **Overview:** APT Medical Inc. focuses on the research, development, production, and sale of cardiovascular interventional medical devices in China with a market cap of CN¥33.13 billion. **Operations:** The company generates revenue of CN¥2.72 billion from its medical products segment. **Estimated Discount To Fair Value:** 31.5% APT Medical appears undervalued, trading 31.5% below its estimated fair value and significantly under its future cash flow value. Recent earnings show strong growth with Q1 net income at CNY 229.44 million, up from CNY 183.15 million the previous year. The company has initiated a share buyback program worth up to CNY 100 million, indicating confidence in its financial health and potential for sustained profitability despite an unstable dividend track record. - Our earnings growth report unveils the potential for significant increases in APT Medical's future results. - Navigate through the intricacies of APT Medical with our comprehensive financial health report here. ## LianChuang Electronic TechnologyLtd (SZSE:002036) **Overview:** LianChuang Electronic Technology Co., Ltd specializes in the research, development, production, and sale of optics and optoelectronics both in China and internationally, with a market cap of CN¥9.06 billion. **Operations:** The company generates revenue from its optics and optoelectronics segments, serving both domestic and international markets. **Estimated Discount To Fair Value:** 49% LianChuang Electronic Technology is trading at 49% below its estimated fair value, significantly under its projected future cash flow value of CNY 17.66 per share. Despite a challenging financial year with a net loss of CNY 1,011.34 million and declining sales, the company plans a private placement to raise up to CNY 300 million, potentially bolstering liquidity. Revenue is forecasted to grow faster than the Chinese market average over the next few years. - Our expertly prepared growth report on LianChuang Electronic TechnologyLtd implies its future financial outlook may be stronger than recent results. - Delve into the full analysis health report here for a deeper understanding of LianChuang Electronic TechnologyLtd. ## Jiangsu Haili Wind Power Equipment Technology (SZSE:301155) **Overview:** Jiangsu Haili Wind Power Equipment Technology Co., Ltd. (SZSE:301155) specializes in the manufacturing of wind power equipment and has a market cap of CN¥13.42 billion. **Operations:** The company's revenue segments include the production and sales of wind power equipment. **Estimated Discount To Fair Value:** 30.3% Jiangsu Haili Wind Power Equipment Technology is trading at 30.3% below its estimated fair value, with a future cash flow value of CNY 100.86 per share. Despite a challenging first quarter in 2026, with decreased sales and net income compared to the previous year, the company reported significant earnings growth for 2025. Future revenue and earnings are expected to grow faster than the Chinese market average, indicating potential undervaluation based on cash flows. - The analysis detailed in our Jiangsu Haili Wind Power Equipment Technology growth report hints at robust future financial performance. - Click here and access our complete balance sheet health report to understand the dynamics of Jiangsu Haili Wind Power Equipment Technology. ## Where To Now? - Navigate through the entire inventory of 414 Undervalued Global Stocks Based On Cash Flows here. - Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. - Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. ## Looking For Alternative Opportunities? - Explore high-performing small cap companies that haven't yet garnered significant analyst attention. - Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. - Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation.** We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### Related Stocks - [002036.CN](https://longbridge.com/en/quote/002036.CN.md) - [301155.CN](https://longbridge.com/en/quote/301155.CN.md) - [688617.CN](https://longbridge.com/en/quote/688617.CN.md) ## Related News & Research - [Unveiling 3 Undiscovered Gems in Asia with Strong Fundamentals](https://longbridge.com/en/news/286824080.md) - [European Undervalued Small Caps With Insider Action For May 2026](https://longbridge.com/en/news/286721352.md) - [3 energy stocks that are quietly becoming the trades of the year](https://longbridge.com/en/news/286790976.md) - [UK unemployment edges up to 5% in March](https://longbridge.com/en/news/286989285.md) - [SMBs target AI, flexible talent to navigate 2026 uncertainty](https://longbridge.com/en/news/286855385.md)